BRIDGE Program
- Program Objective
- This program aims to enhance the feasibility of drug development at the early discovery stage by providing essential data requirements, strategic guidance, and expert discussions to support the optimization of lead compounds and facilitate advancement to subsequent development phases.
- Program Details
- Program period: Apr-Dec, 2026
- Scope of Support:
- Consulting and supplementary studies to improve the development potential of promising compounds within program-affiliated projects.
- Review and advisory sessions on key development issues, sharing evaluation insights, validating lead optimization strategies, and discussing next-step planning, L/O, and other commercialization strategies.
- Expert advisory committee review to establish detailed TPPs, TCPs, and screening flowcharts, which will be shared with principal investigators for implementation guidance.
- Contact
R&D Enabling & Strategy Team: rnd_project@kddf.org